Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach
The International Journal of Biological Markers · 2022-12 · 37 (4) · 349-359
DOI: 10.1177/03936155221123343 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biological Markers, online erschienen am 27.09.2022. Verfasst von Nasrin Amiri-Dashatan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zanjan Metabolic Diseases Research Center, 48539Zanjan University of Medical Sciences, Zanjan, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Ductal, Breast. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shahid Beheshti University of Medical Sciences.
Abstract (Originalsprache)
Background
Invasive ductal carcinoma (IDC) is the most common type of breast cancer so its early detection can lead to a significant decrease in mortality rate. However, prognostic factors for IDC are not adequate and we need novel markers for the treatment of different individuals. Although positron emission tomography and magnetic resonance imaging techniques are available, they are based on morphological features that do not provide any clue for molecular events accompanying cancer progression. In recent years, “omics” approaches have been extensively developed to propose novel molecular signatures of cancers as putative biomarkers, especially in biofluids. Therefore, a mass spectrometry-based metabolomics investigation was performed to find some putative metabolite markers of IDC and potential metabolites with prognostic value related to the estrogen receptor, progesterone receptor, lymphovascular invasion, and human epidermal growth factor receptor 2.
Methods
An untargeted metabolomics study of IDC patients was performed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The multivariate principal component analysis by XCMS online built a model that could separate the study groups and define the significantly altered m/z parameters. The most important biological pathways were also identified by pathway enrichment analysis.
Results
The results showed that the significantly altered metabolites in IDC serum samples mostly belonged to amino acids and lipids. The most important involved pathways included arginine and proline metabolism, glycerophospholipid metabolism, and phenylalanine, tyrosine, and tryptophan biosynthesis.
Conclusions
Significantly altered metabolites in IDC serum samples compared to healthy controls could lead to the development of metabolite-based potential biomarkers after confirmation with other methods and in large cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zanjan Metabolic Diseases Research Center, 48539Zanjan University of Medical Sciences, Zanjan, Iran.
- Proteomics Research Center, 556492Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Clinical Biochemistry, School of Medicine, 48539Zanjan University of Medical Sciences, Zanjan, Iran.
- Department of Basic Sciences, Faculty of Paramedical Sciences, 556492Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 113401Chemistry and Chemical Engineering Research Center of Iran, Tehran, Iran.
- Non-communicable Diseases Research Center, 391934Alborz University of Medical Sciences, Karaj, Iran.
ORCID-Profile: Afsaneh Arefi Oskouie
Förderung
- Shahid Beheshti University of Medical Sciences
Zitieren
APA
Amiri-Dashatan, N., Yekta, R. F., Koushki, M., Arefi Oskouie, A., Esfahani, H., Taheri, S., & Kazemian, E. (2022). Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach. The International Journal of Biological Markers, 37(4), 349-359. https://doi.org/10.1177/03936155221123343
Vancouver
Amiri-Dashatan N, Yekta RF, Koushki M, Arefi Oskouie A, Esfahani H, Taheri S, et al. Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach. The International Journal of Biological Markers. 2022;37(4):349-359. doi:10.1177/03936155221123343
BibTeX
@article{AmiriDashatan2022,
author = {Amiri-Dashatan, Nasrin and Yekta, Reyhaneh Farrokhi and Koushki, Mehdi and Arefi Oskouie, Afsaneh and Esfahani, Hadi and Taheri, Salman and Kazemian, Elham},
title = {Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach},
journal = {The International Journal of Biological Markers},
year = {2022},
volume = {37},
number = {4},
pages = {349--359},
doi = {10.1177/03936155221123343}
}
EUVIMED